Twinning and Multiple Gestations

The incidence of twin and higher-order multiple births has risen significantly, making a clear understanding of their origins and complications essential for any clinician. At its core, the profound differences in risk between twin pregnancies stem from their very conception—specifically, the number of eggs fertilized and the timing of embryonic division. Mastering the chorionicity (number of placentas) and amnionicity (number of amniotic sacs) is not academic; it is the critical framework that predicts and guides management of serious, life-threatening conditions unique to these pregnancies.

Foundations: Zygosity, Chorionicity, and Amnionicity

To navigate twin pregnancies, you must first distinguish between zygosity (genetic origin) and placentation (physical structure of the membranes). These are related but distinct concepts. Dizygotic twins, which account for about two-thirds of twins in spontaneous pregnancies, result from the fertilization of two separate ova by two separate sperm. They are genetically as similar as any siblings and are always dichorionic diamniotic (DCDA). This means each twin has its own placenta (or two distinct placental masses) and its own amniotic sac, separated by a thick, four-layered membrane.

Monozygotic twins, conversely, originate from a single fertilized egg that splits into two embryos. Their genetic identity is nearly identical. Crucially, the type of placenta and membranes they share depends entirely on when this split occurs after fertilization. This relationship between timing and membrane status is a foundational pillar of embryo development and risk stratification.

The Critical Timeline of Embryonic Splitting

The placentation of monozygotic twins is a direct map of the timing of the split. This timeline is non-negotiable for clinical reasoning:

• Days 1–3 (Morula Stage): Splitting at this very early stage, before the cells that will form the placenta (trophoblast) have begun to differentiate, results in dichorionic diamniotic (DCDA) twins. Each developing embryo forms its own chorion (the outer membrane that becomes the placenta) and amnion (the inner sac). These twins, while monozygotic, have separate placentas and sacs, just like dizygotic twins. They account for about 25% of monozygotic twins.
• Days 4–8 (Blastocyst Stage): This is the most common timing for splitting, occurring after the chorion has formed but before the amnion has developed. The result is monochorionic diamniotic (MCDA) twins. They share a single placenta but have separate amniotic sacs, divided by a thin, two-layered membrane. Approximately 75% of monozygotic twins are MCDA.
• Days 8–12: Splitting occurs after the amnion has formed. The embryos now share both the inner amniotic sac and the outer chorionic sac, resulting in monochorionic monoamniotic (MCMA) twins. This rare configuration (<1% of monozygotic twins) carries a high risk of cord entanglement.
• After Day 13: Incomplete splitting of the embryonic disc leads to conjoined twins. The degree and location of connection vary widely.

The clinical takeaway is immediate: All dizygotic twins are DCDA. Monozygotic twins can be DCDA, MCDA, or MCMA, with MCDA being the most common. Determining chorionicity via ultrasound in the first trimester is therefore one of the most important steps in managing a twin pregnancy.

Complications Arising from Shared Placentation

The shared circulation of a monochorionic placenta is the engine for several unique and serious complications. The most significant is Twin-to-Twin Transfusion Syndrome (TTTS). In an MCDA placenta, vascular connections (artery-to-vein anastomoses) normally allow blood to flow between the twins' circulations. TTTS occurs when these connections are unbalanced, leading to a net flow of blood from one twin (the donor) to the other (the recipient).

This creates a dangerous imbalance. The donor twin becomes hypovolemic (low blood volume), leading to oligohydramnios (low amniotic fluid), growth restriction, and a "stuck" appearance against the uterine wall. The recipient twin becomes hypervolemic (high blood volume), leading to polyhydramnios (excess amniotic fluid), cardiac strain, cardiomyopathy, and hydrops. Untreated, TTTS has a very high mortality rate for both twins. Management involves meticulous ultrasound surveillance and may require invasive fetal therapy like laser ablation of the connecting placental vessels.

Other monochorionic complications include Selective Intrauterine Growth Restriction (sIUGR), where unequal placental sharing stunts one twin's growth, and Twin Anemia Polycythemia Sequence (TAPS), a milder, chronic form of blood exchange. For MCMA twins, the ever-present risk of cord entanglement necessitates intense monitoring and often early delivery.

Management Principles and Surveillance

Management of a multiple gestation is dictated by chorionicity. All twin pregnancies are considered high-risk, but the surveillance protocol diverges sharply:

• Dichorionic (DCDA) Twins: Management focuses on screening for complications common to all pregnancies, like preeclampsia and gestational diabetes (which are more frequent with twins), and monitoring for discordant growth. Ultrasounds are typically performed every 4 weeks.
• Monochorionic (MCDA/MCMA) Twins: These require specialized fetal medicine care. Surveillance includes ultrasound scans every 2 weeks from 16 weeks onward to meticulously assess amniotic fluid volume (using the deepest vertical pocket measurement) and fetal bladders to screen for the onset of TTTS or sIUGR. Delivery is usually planned earlier, often between 34-37 weeks for MCDA and even earlier (32-34 weeks) for MCMA twins due to cord entanglement risks.

Common Pitfalls

1. Assuming "Identical" Means "Identical Risk": The lay term "identical" refers only to genetics (monozygosity). Clinically, the placentation (chorionicity) determines risk. Calling monochorionic twins "identical" without clarifying the shared placenta and its associated dangers is a critical oversight.
2. Failing to Determine Chorionicity Early: The optimal window for determining chorionicity via ultrasound is the first trimester (by 14 weeks), assessing the lambda sign (thick, triangular tissue where DCDA membranes meet the placenta) or the T-sign (thin, T-shaped membrane insertion in MCDA). Missing this window or failing to document it clearly can lead to inappropriate low-risk management of a high-risk monochorionic pregnancy.
3. Attributing Size Discordance to TTTS Alone: While significant size difference can be part of TTTS, it is not diagnostic. Selective IUGR in a monochorionic placenta can cause discordance without the characteristic fluid imbalances of TTTS. Conversely, in dichorionic twins, size discordance is usually due to unequal placental function or genetic potential, not vascular connections. The diagnostic criteria for TTTS are specific: polyhydramnios in one sac (deepest vertical pocket >8 cm) and oligohydramnios in the other (deepest vertical pocket <2 cm).

Summary

• Dizygotic twins arise from two separate fertilization events and are always dichorionic diamniotic (DCDA), meaning they have separate placentas and amniotic sacs.
• Monozygotic twins form from the splitting of a single zygote; their membrane type depends strictly on the timing of the split: early (DCDA), days 4-8 (monochorionic diamniotic/MCDA), days 8-12 (monochorionic monoamniotic/MCMA), or late (conjoined).
• The critical clinical division is chorionicity. Monochorionic pregnancies (all sharing one placenta) are at high risk for unique complications like Twin-to-Twin Transfusion Syndrome (TTTS) due to shared placental vasculature.
• First-trimester ultrasound to determine chorionicity is mandatory, as it dictates the entire surveillance and management plan, with monochorionic twins requiring specialist care and biweekly scans.
• Never equate genetic identity (monozygosity) with clinical management; the structure of the placenta and membranes, established in the first two weeks after conception, is the true determinant of risk.